CBUS vs. AVD, LFVN, CGA, NAII, EVGN, MTEX, BIOX, LWAY, CSV, and LMNR
Should you be buying Cibus stock or one of its competitors? The main competitors of Cibus include American Vanguard (AVD), LifeVantage (LFVN), China Green Agriculture (CGA), Natural Alternatives International (NAII), Evogene (EVGN), Mannatech (MTEX), Bioceres Crop Solutions (BIOX), Lifeway Foods (LWAY), Carriage Services (CSV), and Limoneira (LMNR).
American Vanguard (NYSE:AVD) and Cibus (NASDAQ:CBUS) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, community ranking, dividends, analyst recommendations, profitability and media sentiment.
American Vanguard received 288 more outperform votes than Cibus when rated by MarketBeat users. However, 100.00% of users gave Cibus an outperform vote while only 61.13% of users gave American Vanguard an outperform vote.
In the previous week, Cibus had 1 more articles in the media than American Vanguard. MarketBeat recorded 14 mentions for Cibus and 13 mentions for American Vanguard. Cibus' average media sentiment score of 0.30 beat American Vanguard's score of -0.09 indicating that American Vanguard is being referred to more favorably in the media.
American Vanguard has a net margin of 1.22% compared to American Vanguard's net margin of -12,313.28%. Cibus' return on equity of 2.20% beat American Vanguard's return on equity.
American Vanguard has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.
79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 33.8% of Cibus shares are owned by institutional investors. 9.3% of American Vanguard shares are owned by insiders. Comparatively, 49.4% of Cibus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
American Vanguard presently has a consensus target price of $18.00, indicating a potential upside of 108.09%. Cibus has a consensus target price of $25.00, indicating a potential upside of 31.65%. Given Cibus' higher probable upside, analysts clearly believe American Vanguard is more favorable than Cibus.
American Vanguard has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Cibus has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500.
Summary
American Vanguard beats Cibus on 12 of the 17 factors compared between the two stocks.
Get Cibus News Delivered to You Automatically
Sign up to receive the latest news and ratings for CBUS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CBUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
